Sana Biotechnology's total assets for Q4 2025 were $416.89M, a decrease of -4.26% from the previous quarter. SANA total liabilities were $256.01M for the fiscal quarter, a 6.61% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.